Summary
Intravenous administration of Corynebacterium parvum (C. parvum) to mice during a primary immune response against tumor alloantigens impairs their ability to generate memory cell-mediated cytotoxicity (CMC) in response to an intraperitoneal rechallenge with the same tumor alloantigens. Decreased CMC was observed in spleen and mesenteric lymph nodes, whereas CMC of lymphoid populations from the peritoneal cavity was merely delayed, reaching comparable levels to those found in control animals by day 5. Serum levels of cytotoxic antibody were unaffected, indicating that C. parvum administered during a primary immune response has selective effects on the cytotoxic memory response.
Similar content being viewed by others
References
Asherson GL, Alwood GG (1971) Depression of delayed hypersensitivity by pretreatment with Freud-type adjuvants. I. Description of the phenomenon. Clin Exp Immunol 9:249
Berd DA, Michell MS (1976) Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice. Cancer Res 36:4119
Brunner KT, Engers HD, Cerottini JC (1976) The 51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In: Bloom BR, David JR (eds) In vitro methods in cell-mediated and tumor immunity. Academic, New York, p 423
Frost P, Lance EM (1973) The relationship of lymphocyte trapping to the mode of action of adjuvants. In: Immunopotentiation (Ciba Foundation Symposium no. 18). Associated Scientific Publishers, New York, p 29
Greenberg CS, Dimitrov NV (1976) The effect of hydrocortisone on the immune response of mice treated with Corynebacterium parvum. Clin Immunol Immunopathol 5:264
Hall BM, Dorsch S, Roser B (1978b) The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med 148:878
Hall BM, Dorsch S, Roser B (1978b) The cellular basis of allograft rejection in vivo. II. The nature of memory cells mediating second set heart graft rejection. J Exp Med 148:890
Milas L, Hunter N, Withers HR (1974) Corynebacterium parvum-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice. Cancer Res 34:613
Murahata RI, Zighelboim J (1979a) Inhibition of memory cell-mediated cytotoxic response by systemic administration of Corynebacterium parvum. Cell Immunol 42:289
Murahata RI, Zighelboim J (1979b) Inhibition of cell-mediated cytotoxicity to tumor alloantigens by systemic administration of Corynebacterium parvum. Cancer Immunol Immunother 6:101
Scott MT (1972a) Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte, and GVH reactivity. Cell Immunol 5:459
Scott MT (1972b) Biological effects of the adjuvant Corynebacterium parum. II. Evidence for macrophage-T-cell interaction. Cell Immunol 5:469
Scott MT (1974a) Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen. Cell Immunol 13:251
Scott MT (1974b) Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection. J Natl Cancer Inst 53:855
Warr GW, Slijivic VC (1974) Enhancement and depression of antibody response in mice caused by Corynebacterium parvum. Clin Exp Immunol 17:519
Woodruff MFA, Dunbar N (1973) The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice. In: Immunopotentiation (Ciba Foundation Symposium no 18). Associated Scientific Publishers, New York, p 287
Woodruff MFA, Gaffar A, Dunbar N, Whitehead VL (1976) Effect of C. parvum on immunization with irradiated tumor cells. Br J Cancer 33:491
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murahata, R.I., Zighelboim, J. Systemic administration of Corynebacterium parvum during sensitization to tumor alloantigen-modified response to rechallenge. Cancer Immunol Immunother 8, 257–261 (1980). https://doi.org/10.1007/BF00206044
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00206044